A hematopoietic contribution to microhemorrhage formation during antiviral CD8 T cell-initiated blood-brain barrier disruption

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Johnson, Holly L ^a   Chen, Yi ^b   Suidan, Georgette L ^b   McDole, Jeremiah R ^b   Lohrey, Anne K ^b   Hanson, Lisa M ^a   Jin, Fang ^a   Pirko, Istvan ^a   Johnson, Aaron J ^a,b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Blood brain barrier; CD8 t cell; Hematopoietic factors; Hemorrhage; MRI; Theiler's murine encephalomyelitis

Indexed keywords

GADOLINIUM; GLIAL FIBRILLARY ACIDIC PROTEIN; VIRUS PROTEIN; ANTIANEMIC AGENT; CAPSID PROTEIN; FLUORESCEIN ISOTHIOCYANATE; VP2 PROTEIN, DEPENDOVIRUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD BRAIN BARRIER; BLOOD BRAIN BARRIER DISRUPTION; BLOOD VESSEL PERMEABILITY; BRAIN HEMORRHAGE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENCEPHALITIS; EXPERIMENTAL MODEL; HEMATOPOIETIC CELL; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NEUTROPHIL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PEPTIDE INDUCED FATAL SYNDROME; ANIMAL; BONE MARROW TRANSPLANTATION; CAPILLARY PERMEABILITY; CARDIOVIRUS INFECTION; DISEASE MODEL; DRUG EFFECT; FLOW CYTOMETRY; METABOLISM; METHODOLOGY; MOTOR ACTIVITY; MOUSE STRAIN; PATHOGENICITY; PHYSIOLOGY; ROTAROD TEST; VIROLOGY;

ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; BONE MARROW TRANSPLANTATION; CAPILLARY PERMEABILITY; CAPSID PROTEINS; CARDIOVIRUS INFECTIONS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMATINICS; INTRACRANIAL HEMORRHAGES; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; ROTAROD PERFORMANCE TEST; THEILOVIRUS; VIRAL PROTEINS;

EID: 84862821530     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-60     Document Type: Article

References (55)

1. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201. 10.1016/j.neuron.2008.01.003, 18215617.
2. Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LT, Raengsakulrach B, Loan HT, Day NP, Farrar J, Myint KS, Warrell MJ, James WS, Nisalak A, White NJ. Neurological manifestations of dengue infection. Lancet 2000, 355:1053-1059. 10.1016/S0140-6736(00)02036-5, 10744091.
3. Janssen HL, Bienfait HP, Jansen CL, van Duinen SG, Vriesendorp R, Schimsheimer RJ, Groen J, Osterhaus AD. Fatal cerebral oedema associated with primary dengue infection. J Infect 1998, 36:344-346. 10.1016/S0163-4453(98)94783-1, 9661954.
4. Pancharoen C, Mekmullica J, Thisyakorn U. Primary dengue infection: what are the clinical distinctions from secondary infection?. Southeast Asian J Trop Med Public Health 2001, 32:476-480.
5. George R, Lam SK. Dengue virus infection: the Malaysian experience. Ann Acad Med Singapore 1997, 26:815-819.
6. Shacklett BL, Cox CA, Wilkens DT, Karlsson KR, Nilsson A, Nixon DF, Price RW. Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection. J Infect Dis 2004, 189:2202-2212. 10.1086/421244, 15181567.
7. Minagar A, Alexander JS. Blood-brain barrier disruption in multiple sclerosis. Mult Scler 2003, 9:540-549. 10.1191/1352458503ms965oa, 14664465.
8. Kirk J, Plumb J, Mirakhur M, McQuaid S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol 2003, 201:319-327. 10.1002/path.1434, 14517850.
9. Plumb J, McQuaid S, Mirakhur M, Kirk J. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol 2002, 12:154-169.
10. Stone LA, Smith ME, Albert PS, Bash CN, Maloni H, Frank JA, McFarland HF. Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age. Neurology 1995, 45:1122-1126.
11. Green R, Scott LK, Minagar A, Conrad S. Sepsis associated encephalopathy (SAE): a review. Front Biosci 2004, 9:1637-1641. 10.2741/1250, 14977574.
12. Sharshar T, Annane D, de la Grandmaison GL, Brouland JP, Hopkinson NS, Françoise G. The neuropathology of septic shock. Brain Pathol 2004, 14:21-33.
13. Medana IM, Turner GD. Human cerebral malaria and the blood-brain barrier. Int J Parasitol 2006, 36:555-568. 10.1016/j.ijpara.2006.02.004, 16616145.
14. Gibbs WN, Kreidie MA, Kim RC, Hasso AN. Acute hemorrhagic leukoencephalitis: neuroimaging features and neuropathologic diagnosis. J Comput Assist Tomogr 2005, 29:689-693. 10.1097/01.rct.0000173843.82364.db, 16163044.
15. Oby E, Janigro D. The blood-brain barrier and epilepsy. Epilepsia 2006, 47:1761-1774. 10.1111/j.1528-1167.2006.00817.x, 17116015.
16. Lacerda-Queiroz N, Rodrigues DH, Vilela MC, Rachid MA, Soriani FM, Sousa LP, Campos RD, Quesniaux VF, Teixeira MM, Teixeira AL. Platelet-activating factor receptor is essential for the development of experimental cerebral malaria. Am J Pathol 2012, 180:246-255. 10.1016/j.ajpath.2011.09.038, 22079430.
17. de Vries NA, Beijnen JH, Boogerd W, van Tellingen O. Blood-brain barrier and chemotherapeutic treatment of brain tumors. Expert Rev Neurother 2006, 6:1199-1209. 10.1586/14737175.6.8.1199, 16893347.
18. Blamire AM, Anthony DC, Rajagopalan B, Sibson NR, Perry VH, Styles P. Interleukin-1β-induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study. J Neurosci 2000, 20:8153-8159.
19. Stoll G, Jander S, Schroeter M. Cytokines in CNS disorders: neurotoxicity versus neuroprotection. J Neural Transm Suppl 2000, 59:81-89.
20. Chavarria A, Alcocer-Varela J. Is damage in central nervous system due to inflammation?. Autoimmun Rev 2004, 3:251-260. 10.1016/j.autrev.2003.09.006, 15246020.
21. Kim JV, Kang SS, Dustin ML, McGavern DB. Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature 2009, 457:191-195. 10.1038/nature07591, 2702264, 19011611.
22. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007, 13:1173-1175. 10.1038/nm1651, 17828272.
23. Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci USA 2009, 106:1977-1982. 10.1073/pnas.0808698106, 2644149, 19174516.
24. Suidan GL, McDole JR, Chen Y, Pirko I, Johnson AJ. Induction of blood brain barrier tight junction protein alterations by CD8 T cells. PLoS One 2008, 3:e3037. 10.1371/journal.pone.0003037, 2516328, 18725947.
25. Suidan GL, Dickerson JW, Chen Y, McDole JR, Tripathi P, Pirko I, Seroogy KB, Johnson AJ. CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions. J Immunol 2010, 184:1031-1040. 10.4049/jimmunol.0902773, 2896014, 20008293.
26. Pirko I, Suidan GL, Rodriguez M, Johnson AJ. Acute hemorrhagic demyelination in a murine model of multiple sclerosis. J Neuroinflammation 2008, 5:31. 10.1186/1742-2094-5-31, 2474604, 18606015.
27. Johnson AJ, Mendez-Fernandez Y, Moyer AM, Sloma CR, Pirko I, Block MS, Rodriguez M, Pease LR. Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndrome. J Immunol 2005, 174:6854-6862.
28. Loke H, Bethell DB, Phuong CX, Dung M, Schneider J, White NJ, Day NP, Farrar J, Hill AV. Strong HLA class I-restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?. J Infect Dis 2001, 184:1369-1373. 10.1086/324320, 11709777.
29. Zivna I, Green S, Vaughn DW, Kalayanarooj S, Stephens HA, Chandanayingyong D, Nisalak A, Ennis FA, Rothman AL. T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severity. J Immunol 2002, 168:5959-5965.
30. Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, Chairunsri A, Sawasdivorn S, Duangchinda T, Dong T, Rowland-Jones S, Yenchitsomanus PT, McMichael A, Malasit P, Screaton G. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003, 9:921-927. 10.1038/nm887, 12808447.
31. Green S, Pichyangkul S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Nisalak A, Kurane I, Rothman AL, Ennis FA. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J Infect Dis 1999, 180:1429-1435. 10.1086/315072, 10515800.
32. Stephens HA, Klaythong R, Sirikong M, Vaughn DW, Green S, Kalayanarooj S, Endy TP, Libraty DH, Nisalak A, Innis BL, Rothman AL, Ennis FA, Chandanayingyong D. HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens 2002, 60:309-318. 10.1034/j.1399-0039.2002.600405.x, 12472660.
33. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J, Ennis FA. Activation of T lymphocytes in dengue virus infections: high levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-γ in sera of children with dengue. J Clin Invest 1991, 88:1473-1480. 10.1172/JCI115457, 295652, 1939640.
34. Skulina C, Schmidt S, Dornmair K, Babbe H, Roers A, Rajewsky K, Wekerle H, Hohlfeld R, Goebels N. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci USA 2004, 101:2428-2433. 10.1073/pnas.0308689100, 356967, 14983026.
35. Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, Friese M, Schröder R, Deckert M, Schmidt S, Ravid R, Rajewsky K. Clonal expansions of CD8+ T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000, 192:393-404. 10.1084/jem.192.3.393, 2193223, 10934227.
36. Johnson AJ, Njenga MK, Hansen MJ, Kuhns ST, Chen L, Rodriguez M, Pease LR. Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor α, γ interferon, perforin, or costimulation through CD28. J Virol 1999, 73:3702-3708. 104145, 10196262.
37. Lin X, Thiemann NR, Pease LR, Rodriguez M. VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of B10 mice. Virology 1995, 214:91-99. 10.1006/viro.1995.9951, 8525642.
38. McDole JR, Danzer SC, Pun RY, Chen Y, Johnson HL, Pirko I, Johnson AJ. Rapid formation of extended processes and engagement of Theiler's virus-infected neurons by CNS-infiltrating CD8 T cells. Am J Pathol 2010, 177:1823-1833. 10.2353/ajpath.2010.100231, 2947278, 20813972.
39. Johnson AJ, Upshaw J, Pavelko KD, Rodriguez M, Pease LR. Preservation of motor function by inhibition of CD8+ virus peptide-specific T cells in Theiler's virus infection. FASEB J 2001, 15:2760-2762.
40. Kovacevic N, Henderson JT, Chan E, Lifshitz N, Bishop J, Evans AC, Henkelman RM, Chen XJ. A three-dimensional MRI atlas of the mouse brain with estimates of the average and variability. Cereb Cortex 2005, 15:639-645.
41. Denic A, Macura SI, Mishra P, Gamez JD, Rodriguez M, Pirko I. MRI in rodent models of brain disorders. Neurotherapeutics 2011, 8:3-18. 10.1007/s13311-010-0002-4, 3075741, 21274681.
42. Pirko I, Gamez J, Johnson AJ, Macura SI, Rodriguez M. Dynamics of MRI lesion development in an animal model of viral-induced acute progressive CNS demyelination. Neuroimage 2004, 21:576-582. 10.1016/j.neuroimage.2003.09.037, 14980559.
43. Pirko I, Johnson AJ, Chen Y, Lindquist DM, Lohrey AK, Ying J, Dunn RS. Brain atrophy correlates with functional outcome in a murine model of multiple sclerosis. Neuroimage 2011, 54:802-806. 10.1016/j.neuroimage.2010.08.055, 20817104.
44. Pirko I, Nolan TK, Holland SK, Johnson AJ. Multiple sclerosis: pathogenesis and MR imaging features of T1 hypointensities in a murine model. Radiology 2008, 246:790-795. A published erratum appears in Radiology 2008, 248:322, 10.1148/radiol.2463070338, 18309014.
45. Robb RA. 3-D visualization in biomedical applications. Annu Rev Biomed Eng 1999, 1:377-399. 10.1146/annurev.bioeng.1.1.377, 11701494.
46. Robb RA. The biomedical imaging resource at Mayo Clinic. IEEE Trans Med Imaging 2001, 20:854-867. 10.1109/42.952724, 11585203.
47. Rubin P, Gash DM, Hansen JT, Nelson DF, Williams JP. Disruption of the blood-brain barrier as the primary effect of CNS irradiation. Radiother Oncol 1994, 31:51-60. 10.1016/0167-8140(94)90413-8, 8041898.
48. van Vulpen M, Kal HB, Taphoorn MJB, El Sharouni SY. Changes in blood-brain barrier permeability induced by radiotherapy: implications for timing of chemotherapy?. Oncol Rep 2002, 9:683-688.
49. Knickelbein JE, Khanna KM, Yee MB, Baty CJ, Kinchington PR, Hendricks RL. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 2008, 322:268-271. 10.1126/science.1164164, 2680315, 18845757.
50. Smyth MJ, Kelly JM, Sutton VR, Davis JE, Browne KA, Sayers TJ, Trapani JA. Unlocking the secrets of cytotoxic granule proteins. J Leukoc Biol 2001, 70:18-29.
51. Weis SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005, 437:497-504. 10.1038/nature03987, 16177780.
52. Baluna R, Vitetta ES. Vascular leak syndrome: a side effect of immunotherapy. Immunopharmacology 1997, 37:117-132. 10.1016/S0162-3109(97)00041-6, 9403331.
53. Engelhardt B. Molecular mechanisms involved in T cell migration across the blood-brain barrier. J Neural Transm 2006, 113:477-485. 10.1007/s00702-005-0409-y, 16550326.
54. Jin R, Yang G, Li G. Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol Dis 2010, 38:376-385. 10.1016/j.nbd.2010.03.008, 2862862, 20302940.
55. Wosik K, Biernacki K, Khouzam MP, Prat A. Death receptor expression and function at the human blood brain barrier. J Neurol Sci 2007, 259:53-60. 10.1016/j.jns.2006.08.018, 17395209.